The latest cancer drugs news
Browsing: Cancer Drug News
The price of a drug should be based on its therapeutic benefits – not just what the market will bear
Nicole Hassoun, Binghamton University, State University of New York The average price for an orphan…
Promising new treatment strategy for men with drug-resistant prostate cancer
A new experimental drug could offer a promising approach to treating men with advanced prostate…
Scientists develop new drug that targets pathway found in several hard-to-treat cancers
After decades of no luck, scientists have finally found a way to target the KRAS…
SU2C research leads to FDA approval of new first-line treatment for colorectal cancer
The FDA recently approved the immunotherapy drug pembrolizumab as a first-line treatment for patients with…
Lithuanian researchers propose combination of methods to improve anticancer drug delivery
Application of low-intensity pulsed ultrasound in combination with microbubbles might enhance the delivery of chemotherapy…
New drug inhibits the growth of cancer cells
A newly developed compound starves cancer cells by attacking their “power plants” — the so-called…
Common anti-diarrhoea drug can induce death of aggressive brain cancer cells
A common drug that is usually prescribed to treat diarrhoea may also be a powerful weapon…
Protein twist and squeeze confers cancer drug resistance
In 1986, cellular biochemist Kazumitsu Ueda, currently at Kyoto University’s Institute for Integrated Cell-Material Sciences…
FDA approves pralsetinib for RET-altered thyroid cancers
On December 1, 2020, the Food and Drug Administration approved pralsetinib for adult and paediatric…
Acalabrutinib demonstrated superior progression-free survival for r/r chronic lymphocytic leukaemia patients
Acalabrutinib, a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European…